VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV:WML) (OTCQB:WMLLF) (SSE: WMLCL) (Frankfurt: EJZN), provides a corporate update. Operational Activity Wealth is wrapping up its drilling program at the Laguna Verde project (see press release of December 21, 2017), part of a comprehensive brine evaluation program…
DetailsGlobeNewswire•February 14, 2018 VANCOUVER, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (WML.V)(WMLLF)(SSE:WMLCL)(EJZN.F), reports that it has strengthened its board of directors with the appointment of Stefan Schauss to serve as a director. “Mr. Schauss brings to Wealth decades of experience in the electric battery, green power…
DetailsBusiness Wire•January 25, 2018 LOS ANGELES–(BUSINESS WIRE)– CURE Pharmaceutical (OTCQB: CURR) (“CURE”), an innovative drug delivery and development company, today named Dr. Vered Gigi, Vice President of Strategy and Business Development. Dr. Gigi will oversee CURE’s strategy to deliver sustained growth and diversified revenue. “We are starting a pivotal year for CURE, focusing on both…
DetailsDecember 21, 2017 08:00 ET | Source: Wealth Minerals Ltd. VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV:WML) (OTCQB:WMLLF) (SSE:WMLCL) (Frankfurt:EJZN), provides an end of year shareholder update. “We’re very happy to report a year of positive results and steady progress,” states Wealth’s CEO Henk…
DetailsTest Work Demonstrates that Tenova Advanced Technologies’ Process Technology can be Successfully Applied to the Laguna Verde Surface Brines November 16, 2017 08:00 ET VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSX-V:WML) (OTCQB:WMLLF) (SSE:WMLCL) (Frankfurt:EJZN) announces that it has received positive results from its previously…
DetailsCURE Pharmaceutical Adds New VP of Strategy and Business Development January 25, 2018 LOS ANGELES–(BUSINESS WIRE)– CURE Pharmaceutical (OTCQB: CURR) (“CURE”), an innovative drug delivery and development company, today named Dr. Vered Gigi, Vice President of Strategy and Business Development. Dr. Gigi will oversee CURE’s strategy to deliver sustained growth and diversified revenue. “We are…
DetailsOXNARD, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced the launch of their new brand initiative, inspired by the company’s mission to support patient needs for better delivery of medication. “Our new branding offers an opportunity to elevate awareness around the challenges patients experience…
DetailsOXNARD, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, will be a presenting company at the 2018 Biotech Showcase in San Francisco, CA, taking place January 8 -10, 2018. “We look forward to sharing how CURE can improve the delivery of pharmaceuticals to improve patient…
Details